JP2005514418A5 - - Google Patents

Download PDF

Info

Publication number
JP2005514418A5
JP2005514418A5 JP2003557981A JP2003557981A JP2005514418A5 JP 2005514418 A5 JP2005514418 A5 JP 2005514418A5 JP 2003557981 A JP2003557981 A JP 2003557981A JP 2003557981 A JP2003557981 A JP 2003557981A JP 2005514418 A5 JP2005514418 A5 JP 2005514418A5
Authority
JP
Japan
Prior art keywords
nitrogen
group
hydroxy
optionally
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003557981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514418A (ja
Filing date
Publication date
Priority claimed from HU0200109A external-priority patent/HUP0200109D0/hu
Priority claimed from HU0204362A external-priority patent/HUP0204362D0/hu
Application filed filed Critical
Priority claimed from PCT/HU2003/000003 external-priority patent/WO2003057664A1/en
Publication of JP2005514418A publication Critical patent/JP2005514418A/ja
Publication of JP2005514418A5 publication Critical patent/JP2005514418A5/ja
Pending legal-status Critical Current

Links

JP2003557981A 2002-01-11 2003-01-10 カルボキサミジン誘導体及び血管疾患の治療におけるそれらの使用 Pending JP2005514418A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0200109A HUP0200109D0 (en) 2002-01-11 2002-01-11 Compounds having pharmaceutical activity
HU0204362A HUP0204362D0 (en) 2002-12-17 2002-12-17 Compounds having pharmaceutical activity
PCT/HU2003/000003 WO2003057664A1 (en) 2002-01-11 2003-01-10 Carboxamidine derivatives and their use in the treatment of vascular diseases

Publications (2)

Publication Number Publication Date
JP2005514418A JP2005514418A (ja) 2005-05-19
JP2005514418A5 true JP2005514418A5 (https=) 2006-03-02

Family

ID=90001534

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003557981A Pending JP2005514418A (ja) 2002-01-11 2003-01-10 カルボキサミジン誘導体及び血管疾患の治療におけるそれらの使用

Country Status (17)

Country Link
US (5) US7384936B2 (https=)
EP (1) EP1492763A1 (https=)
JP (1) JP2005514418A (https=)
KR (1) KR20040089102A (https=)
CN (1) CN1615296A (https=)
AU (1) AU2003202104B8 (https=)
BR (1) BR0306778A (https=)
CA (1) CA2471752A1 (https=)
HR (1) HRP20040558A2 (https=)
IL (1) IL162941A0 (https=)
MX (1) MXPA04006716A (https=)
NO (1) NO20043029L (https=)
NZ (1) NZ533795A (https=)
PL (1) PL371251A1 (https=)
RS (1) RS60604A (https=)
RU (1) RU2320330C2 (https=)
WO (1) WO2003057664A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514418A (ja) * 2002-01-11 2005-05-19 ビオレックス クタトー エス フェイレストェー アールテー. カルボキサミジン誘導体及び血管疾患の治療におけるそれらの使用
US8540985B2 (en) 2008-06-26 2013-09-24 Orphazyme Aps Use of Hsp70 as a regulator of enzymatic activity
RU2013125923A (ru) 2010-11-30 2015-01-10 Орфазиме Апс СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
DK2892540T3 (en) * 2012-09-06 2018-11-19 Mcpharma Biotech Inc TREATMENT OF DIARRES AND DRAWN DIARRES WITH RESISTANT POTATO STARCH
US10709700B2 (en) 2014-09-15 2020-07-14 Orphazyme A/S Arimoclomol formulation
AU2017240042B2 (en) 2016-04-01 2019-09-19 3M Innovative Properties Company Hearing protection device and method of forming same
EP3442530A1 (en) 2016-04-13 2019-02-20 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
KR20210059796A (ko) 2016-04-29 2021-05-25 오르파짐 에이/에스 글루코세레브로시다제 연관 장애를 치료하기 위한 아리모클로몰
KR20230128462A (ko) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177578B (en) 1976-08-27 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
EP0369944A1 (de) 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
GB9017351D0 (en) 1990-08-08 1990-09-19 Wellcome Found Medicaments for treatment of atherosclerosis
EP0495750A3 (en) 1991-01-14 1992-09-16 Ciba-Geigy Ag Heterocyclic hydroxylamine
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5780498A (en) * 1993-11-01 1998-07-14 Ciba-Geigy Japan Limited Endothelin receptor antagonists
US5919796A (en) * 1994-05-06 1999-07-06 Biorex Kutato Es Fejleszto Rt. Hydroximic acid derivatives, pharmaceutical compositions containing them, and processes for preparing the same
HU218480B (hu) 1995-06-15 2000-09-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HU9502843D0 (en) 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
HU220971B1 (hu) 1997-04-03 2002-07-29 BIOREX Kutató és Fejlesztő Rt. Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására
HUP9702365A3 (en) * 1997-04-22 1999-09-28 Biorex Kutato Fejlesztoe Kft Application of hydroxilamin-derivatives, as well as process and composition for increase of weather extreme resistent by cultivated plants
HU226617B1 (en) 1998-12-14 2009-04-28 Cytrx Corp Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
HUP9900475D0 (en) 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
HUP0001583A2 (hu) * 2000-04-18 2002-11-28 BIOREX Kutató és Fejlesztő Rt. Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
JP2005514418A (ja) * 2002-01-11 2005-05-19 ビオレックス クタトー エス フェイレストェー アールテー. カルボキサミジン誘導体及び血管疾患の治療におけるそれらの使用
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases

Similar Documents

Publication Publication Date Title
RU2219167C2 (ru) N-замещенные аминотетралины как лиганды для рецептора y5 нейропептида y, полезные при лечении ожирения и других расстройств
RU2013108641A (ru) Способ лечения офтальмологических заболеваний с использованием соединений ингибиторов киназы в пролекарственных формах
RU2011105151A (ru) Азольные соединения
RU2010126105A (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
JP2013545798A5 (https=)
RU2008110949A (ru) Соединения и композиции-иммуносупрессанты
JP2017523972A5 (https=)
RU2006146970A (ru) Бициклические гетероциклы и их применение в качестве ингибиторов вич интегразы
NO20056007L (no) Dobbel NK1/NK3 antagonister for behandling av schizofreni
JP2015509535A5 (https=)
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
JP2004502670A5 (https=)
JP2017214387A5 (https=)
JP2011526594A5 (https=)
JP2005514418A5 (https=)
JP2011503199A5 (https=)
RU2005103618A (ru) Ингибирующие циклооксигеназу-2 (цог-2) производные пиридина
RU2011140869A (ru) Пиперазиновое соединение, ингибирующее простагландин-d-синтазу
JP2006507247A5 (https=)
MA21227A1 (fr) 4-4-4-2-(2,4-difluorophenyl)-2-2(1h-azolylmethyl)-1,3-dioxolanne-'-yl methoxy phenyl-1-piperazinyl phenyl triazolones.
AU2015218775C1 (en) Antimitotic amides for the treatment of cancer and proliferative disorders
MY135954A (en) Crystalline form of (s)-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid
JP2011510072A5 (https=)
RU2003131970A (ru) Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств